BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.41 Cr | ₹1.55 Cr | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.41 Cr |
| Mar2024 | ₹1.55 Cr |
| Mar2023 | ₹0.70 Cr |
| Mar2022 | ₹0.60 Cr |
| Mar2021 | ₹2.63 Cr |
How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.41 Cr | Negative | |
| Mar2024 | ₹1.55 Cr | 120.34 | |
| Mar2023 | ₹0.70 Cr | 16.39 | |
| Mar2022 | ₹0.60 Cr | -77.05 | |
| Mar2021 | ₹2.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹118.9 Cr | -4.7% | 8.6% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.7% |
8.6% |
-19.9% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses